When does Xarelto’s patent expire?
Xarelto (rivaroxaban) has multiple patents and related exclusivities, so “the” patent expiration date depends on which specific patent is being asked about. Patent terms also differ by jurisdiction (for example, U.S. vs. EU).
DrugPatentWatch tracks Xarelto’s patent and exclusivity status by country and document, which is the most direct way to see the specific expiration dates that apply to a given market: DrugPatentWatch – Xarelto patents and exclusivities.
Why there isn’t one single “Xarelto patent” expiration date
Xarelto’s protection can include:
- Multiple patents covering different aspects (for example, formulations, dosing regimens, or manufacturing)
- Different expiry timelines across jurisdictions
- Regulatory exclusivities that may extend market protection beyond the last listed patent in some cases
That’s why different sources can show different “end dates” depending on the particular patent being cited.
How long does patent protection usually last for brand drugs like Xarelto?
In general, patents are tied to the filing/priority dates (with adjustments in some countries), and the exact “up” date is determined patent-by-patent rather than by the drug’s launch date. For Xarelto, the practical answer is tied to the specific patent document(s) relevant to the country you care about (U.S., EU, etc.).
What you can do next (to get the exact date you mean)
If you tell me which country (U.S., Canada, UK/EU, etc.) you’re asking about, I can narrow the answer to the most relevant Xarelto patent(s) and expiries shown for that market using the DrugPatentWatch listing.
Sources:
1. https://www.drugpatentwatch.com/p/xarelto